Effect of Cherry Concentrate on Brain Activation and Perfusion in Healthy Older Adults
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
Effect of 8 weeks of cherry concentrate supplementation on cognitive function and brain perfusion in healthy older adults
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Jan 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedFirst Submitted
Initial submission to the registry
December 2, 2016
CompletedFirst Posted
Study publicly available on registry
June 6, 2018
CompletedJune 26, 2018
June 1, 2018
4 months
December 2, 2016
June 21, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Brain perfusion
Arterial spin labelling using MRI, measure will be reported as ml/min
Change from baseline to 8 weeks supplementation
Secondary Outcomes (3)
Cognitive function
Change from baseline to 8 weeks supplementation
Brain activation (fMRI)
Change from baseline to 8 weeks supplementation
Plasma nitrite concentration
Change from baseline to 8 weeks supplementation
Study Arms (2)
Cherry concentrate
ACTIVE COMPARATOR8 weeks supplementation with montmorency cherry concentrate
Placebo concentrate
PLACEBO COMPARATOR8 weeks supplementation with placebo isoenergetic cherry concentrate
Interventions
Eligibility Criteria
You may qualify if:
- physically inactive consuming 5 or less portions of fruit per day Addenbrookes cognitive examination III score \>88
You may not qualify if:
- physically active consuming more than 5 portions of fruit per day Addenbrookes cognitive examination III score \<88 Contraindications for MRI
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Joanna L Bowtell, PhD
University of Exeter
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 2, 2016
First Posted
June 6, 2018
Study Start
January 1, 2016
Primary Completion
May 1, 2016
Study Completion
December 1, 2016
Last Updated
June 26, 2018
Record last verified: 2018-06
Data Sharing
- IPD Sharing
- Will not share